Clinical Internal MedicineL. Barth Reller, Steven A. Sahn, Robert W. Schrier |
From inside the book
Results 1-3 of 15
Page 187
... propranolol , is added in progressively increasing doses . Patients with severe but not malignant hypertension should be started at the second level of therapy . If response is not optimal , a third - level drug such as hydralazine or ...
... propranolol , is added in progressively increasing doses . Patients with severe but not malignant hypertension should be started at the second level of therapy . If response is not optimal , a third - level drug such as hydralazine or ...
Page 382
... propranolol . Rarely , intrave- nous propranolol is required ; it should be used only in an intensive care unit with cardiology consultation . As soon as possible propranolol should be started orally , since its effect may last for 4 to ...
... propranolol . Rarely , intrave- nous propranolol is required ; it should be used only in an intensive care unit with cardiology consultation . As soon as possible propranolol should be started orally , since its effect may last for 4 to ...
Page 500
... Propranolol is a useful antihypertensive drug ; moreover it illustrates several general principles in pharmacology . Low doses of propranolol block the reflex tachycardia produced by vasodilators ; high doses of propranolol reduce blood ...
... Propranolol is a useful antihypertensive drug ; moreover it illustrates several general principles in pharmacology . Low doses of propranolol block the reflex tachycardia produced by vasodilators ; high doses of propranolol reduce blood ...
Contents
Renal Diseases Fluid and Electrolyte Disorders | 122 |
Hematology and Oncology | 240 |
Neurology | 270 |
Copyright | |
Common terms and phrases
abnormalities abscess activity acute adults agents anemia aortic appears artery arthritis associated bacterial biopsy bleeding blood body brain cardiac cause cell changes chest chronic clinical common commonly concentration cultures decreased detected develop diabetes diagnosis differential disease disorders dose drug early edema effective elevated factors failure fever findings fluid frequently function given glucose heart helpful hepatitis hypertension hypothyroidism important increased indicated infarction infection initial involvement joint laboratory lead lesions less liver loss lower lung major manifestations Medicine muscle myocardial infarction nerve normal obstruction occur organic pain patients peripheral physical examination plasma positive present pressure primary problem produce progressive pulmonary radiograph rarely renal respiratory response result secondary seen serum severe signs skin specific studies suggests symptoms syndrome synovial fluid Table tests therapy tion tissue tract treated treatment tumor urine usually ventricular volume weeks